Syndax price target lowered to $19 from $33 at Barclays

Barclays lowered the firm’s price target on Syndax (SNDX) to $19 from $33 and keeps an Overweight rating on the shares as part of a Q1 earnings preview. The firm says that while difficult to call the quarter with “many moving parts and caveats of sampling error,” its survey of 25 doctors for Syndax’s Revuforj doesn’t point to a beat, but broadening use. Barclays de-risked the model “out of an abundance of caution in the current macro backdrop.”